48 results on '"Campbell, Ross T."'
Search Results
2. Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial
3. Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction
4. Reply: subcutaneous furosemide patch: heart failure decongestion ‘from the comfort of your home’
5. A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies
6. Calcium channel blocker and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction
7. Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials
8. Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection Fraction
9. Influenza vaccination: a simple, safe, and effective treatment for patients with ischaemic heart disease and heart failure
10. Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016
11. Defining Heart Failure Based on Imaging the Heart and Beyond
12. Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
13. Serum bicarbonate and congestion: a potential biomarker for identifying and guiding management in diuretic resistance?
14. Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF
15. Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion
16. Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
17. Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol
18. Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)
19. Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF
20. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction
21. Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction
22. Urinary peptides in heart failure: a link to molecular pathophysiology
23. Sex differences in congestive markers in patients hospitalized for acute heart failure
24. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)
25. Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling
26. A Randomized Trial Comparing The Effect Of Sacubitril/Valsartan To Valsartan On Left Ventricular Remodeling In Patients With Asymptomatic Left Ventricular Systolic Dysfunction After Myocardial Infarction
27. The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
28. Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
29. Lung Ultrasound in Acute Heart Failure
30. Redefining heart failure phenotypes based on ejection fraction
31. Talking to patients with heart failure about end of life
32. Association is not causation: treatment effects cannot be estimated from observational data in heart failure
33. Which patients with heart failure should receive specialist palliative care?
34. How robust are clinical trials in heart failure?
35. Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure
36. Elderly Woman Presenting After a Collapse
37. Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials
38. Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review
39. 22 Retrospective Regional Audit of In-Patient Assessment of Left Ventricular Systolic Function and Guideline-Recommended Prescription of Eplerenone following St-elevation Myocardial Infarction
40. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
41. Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design
42. Diagnosis and Resolution of Löeffler Endocarditis Secondary to Eosinphilic Granulomatosis With Polyangiitis Demonstrated by Cardiac Magnetic Resonance–T2 Mapping
43. Acute heart failure: have we got it all wrong?
44. Comorbidities and Differential Diagnosis in Heart Failure with Preserved Ejection Fraction
45. Reply
46. Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised
47. What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?
48. B-type Natriuretic Peptide and Chest Pain: Do Not Forget Left Ventricle Function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.